Expression of γ-chain cytokine receptors on CD8 + T cells in HIV infection with a focus on IL-7Rα (CD127)

Immunology and Cell Biology

Volumn 90, Issue 4, 2012, Pages 379-387

  Crawley, Angela M ^a,b   Angel, Jonathan B ^a,b,c  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

CD127; CD8 + T cells; HIV; IL 2 receptor g chain; IL 7

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 21 RECEPTOR ALPHA; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 9 RECEPTOR; STAT3 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN;

APOPTOSIS; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOTOXICITY; DISEASE COURSE; DOWN REGULATION; GENETIC POLYMORPHISM; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN GAMMA-CHAINS; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-7;

EID: 84860418562     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.66     Document Type: Review

References (121)

1. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003; 3: 269-279. (Pubitemid 37328680)
2. Camargo JF, Kulkarni H, Agan BK, Gaitan AA, Beachy LA, Srinivas S et al. Responsiveness of T cells to interleukin-7 is associated with higher CD4(+) T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression. J Infect Dis 2009; 199: 1872-1882.
3. Colle JH, Moreau JL, Fontanet A, Lambotte O, Joussemet M, Jacod S et al. Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients-effects of antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 42: 277-285. (Pubitemid 44050004)
4. Carini C, McLane MF, Mayer KH, Essex M. Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection. Eur J Immunol 1994; 24: 2927-2934.
5. Vranjkovic A, Crawley AM, Patey A, Angel JB. IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection. J Leukoc Biol 2011; 89: 499-506.
6. Vranjkovic A, Crawley AM, Gee K, Kumar A, Angel JB. IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8+ T cells. Int Immunol 2007; 19: 1329-1339. (Pubitemid 350131339)
7. Crawley AM, Faucher S, Angel JB. Soluble IL-7Ralpha (sCD127) inhibits IL-7 activity and is increased in HIV infection. J Immunol 2010; 184: 4679-4687.
8. Wang X, Rickert M, Garcia KC. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. Science 2005; 310: 1159-1163. (Pubitemid 41681737)
9. Stauber DJ, Debler EW, Horton PA, Smith KA, Wilson IA. Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. Proc Natl Acad Sci U S A 2006; 103: 2788-2793.
10. LaPorte SL, Juo ZS, Vaclavikova J, Colf LA, Qi X, Heller NM et al. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 2008; 132: 259-272. (Pubitemid 351172435)
11. Wang X, Lupardus P, Laporte SL, Garcia KC. Structural biology of shared cytokine receptors. Annu Rev Immunol 2009; 27: 29-60.
12. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol 2002; 20: 55-72. (Pubitemid 34293420)
13. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-1657. (Pubitemid 34579158)
14. Noguchi M, Adelstein S, Cao X, Leonard WJ. Characterization of the human interleukin-2 receptor gamma chain gene. J Biol Chem 1993; 268: 13601-13608. (Pubitemid 23307791)
15. Bani L, David D, Moreau JL, Cayota A, Nakarai T, Ritz J et al. Expression of the IL-2 receptor gamma subunit in resting human CD4 T lymphocytes: mRNA is constitutively transcribed and the protein stored as an intracellular component. Int Immunol 1997; 9: 573-580. (Pubitemid 27168491)
16. Bani L, Pasquier V, Kryworuchko M, Salamero J, Theze J. Unstimulated human CD4 lymphocytes express a cytoplasmic immature form of the common cytokine receptor gamma-chain. J Immunol 2001; 167: 344-349. (Pubitemid 32567798)
17. Hemar A, Subtil A, Lieb M, Morelon E, Hellio R, Dautry-Varsat A. Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains. J Cell Biol 1995; 129: 55-64.
18. Morelon E, Dautry-Varsat A. Endocytosis of the common cytokine receptor gammac chain. Identification of sequences involved in internalization and degradation. J Biol Chem 1998; 273: 22044-22051. (Pubitemid 28405386)
19. Smith KA. Interleukin-2: inception, impact, and implications. Science 1988; 240: 1169-1176.
20. Greene WC, Robb RJ, Svetlik PB, Rusk CM, Depper JM, Leonard WJ. Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells. J Exp Med 1985; 162: 363-368. (Pubitemid 15028916)
21. Janeway Jr CA, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994; 76: 275-285. (Pubitemid 24046690)
22. Schwaiger S, Wolf AM, Robatscher P, Jenewein B, Grubeck-Loebenstein B. IL-4-producing CD8+ T cells with a CD62L++(bright) phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age. J Immunol 2003; 170: 613-619. (Pubitemid 36026190)
23. Herndler-Brandstetter D, Schwaiger S, Veel E, Fehrer C, Cioca DP, Almanzar G et al. CD25-expressing CD8+ T cells are potent memory cells in old age. J Immunol 2005; 175: 1566-1574. (Pubitemid 41023058)
24. Vingerhoets J, Bisalinkumi E, Penne G, Colebunders R, Bosmans E, Kestens L et al. Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. Immunol Lett 1998; 61: 53-61. (Pubitemid 28161150)
25. Sasson SC, Zaunders JJ, Zanetti G, King EM, Merlin KM, Smith DE et al. Increased plasma interleukin-7 level correlates with decreased CD127 and increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. J Infect Dis 2006; 193: 505-514. (Pubitemid 43202741)
26. Pahwa R, McCloskey TW, Aroniadis OC, Strbo N, Krishnan S, Pahwa S. CD8+ T cells in HIV disease exhibit cytokine receptor perturbation and poor T cell receptor activation but are responsive to gamma-chain cytokine-driven proliferation. J Infect Dis 2006; 193: 879-887.
27. Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135: 3172-3177. (Pubitemid 16250575)
28. Rubin LA, Jay G, Nelson DL. The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol 1986; 137: 3841-3844. (Pubitemid 17215312)
29. Greenberg SJ, Marcon L, Hurwitz BJ, Waldmann TA, Nelson DL. Elevated levels of soluble interleukin-2 receptors in multiple sclerosis. N Engl J Med 1988; 319: 1019-1020.
30. Makis AC, Galanakis E, Hatzimichael EC, Papadopoulou ZL, Siamopoulou A, Bourantas KL. Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis. J Infect 2005; 51: 206-210. (Pubitemid 41554828)
31. Viviani S, Camerini E, Bonfante V, Santoro A, Balzarotti M, Fornier M et al. Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications. Br J Cancer 1998; 77: 992-997. (Pubitemid 28101791)
32. Prince HE, Kleinman S, Williams AE. Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV. J Immunol 1988; 140: 1139-1141. (Pubitemid 18088579)
33. Puri RK, Leland P, Aggarwal BB. Constitutive expression of human immunodeficiency virus type 1 tat gene inhibits interleukin 2 and interleukin 2 receptor expression in a human CD4+ T lymphoid (H9) cell line. AIDS Res Hum Retroviruses 1995; 11: 31-40.
34. Faller EM, McVey MJ, Kakal JA, MacPherson PA. Interleukin-7 receptor expression on CD8 T-cells is downregulated by the HIV Tat protein. J Acquir Immune Defic Syndr 2006; 43: 257-269. (Pubitemid 44674005)
35. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 1993; 262: 1880-1883.
36. Chomarat P, Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 1998; 17: 1-52. (Pubitemid 29014544)
37. Idzerda RL, March CJ, Mosley B, Lyman SD, Vanden Bos T, Gimpel SD et al. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 1990; 171: 861-873. (Pubitemid 20088987)
38. Jung T, Schrader N, Hellwig M, Enssle KH, Neumann C. Soluble human interleukin-4 receptor is produced by activated T cells under the control of metalloproteinases. Int Arch Allergy Immunol 1999; 119: 23-30. (Pubitemid 29204579)
39. Enssle K, Schulz G. Regulation of interleukin-4 activity by soluble interleukin-4 receptors. J Clin Lab Anal 1995; 9: 450-455.
40. Fernandez-Botran R, Vitetta ES. Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. J Exp Med 1991; 174: 673-681.
41. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999; 17: 701-738. (Pubitemid 29241138)
42. Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C et al. Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 2002; 195: 1515-1522. (Pubitemid 34666065)
43. Aung S, Graham BS. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity in vivo. J Immunol 2000; 164: 3487-3493. (Pubitemid 30169798)
44. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000; 1: 426-432.
45. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A 2001; 98: 8732-8737. (Pubitemid 32678096)
46. Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J, Surh CD. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 2002; 195: 1523-1532. (Pubitemid 34666066)
47. Pandey A, Ozaki K, Baumann H, Levin SD, Puel A, Farr AG et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol 2000; 1: 59-64.
48. Hofmeister R, Khaled AR, Benbernou N, Rajnavolgyi E, Muegge K, Durum SK. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev 1999; 10: 41-60. (Pubitemid 29230851)
49. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4: 1191-1198. (Pubitemid 37540688)
50. Huster KM, Busch V, Schiemann M, Linkemann K, Kerksiek KM, Wagner H et al. Selective expression of IL-7 receptor on memory T cells identifies early CD40Ldependent generation of distinct CD8+ memory T cell subsets. Proc Natl Acad Sci U S A 2004; 101: 5610-5615. (Pubitemid 38481204)
51. Harari A, Dutoit V, Cellerai C, Bart PA, Du Pasquier RA, Pantaleo G. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 2006; 211: 236-254. (Pubitemid 43882976)
52. Lefrancois L. Development, trafficking, and function of memory T-cell subsets. Immunol Rev 2006; 211: 93-103. (Pubitemid 43882964)
53. Hand TW, Morre M, Kaech SM. Expression of IL-7 receptor alpha is necessary but not sufficient for the formation of memory CD8 T cells during viral infection. Proc Natl Acad Sci U S A 2007; 104: 11730-11735. (Pubitemid 47175081)
54. Mazzucchelli R, Durum SK. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 2007; 7: 144-154. (Pubitemid 46178275)
55. Boutboul F, Puthier D, Appay V, Pelle O, Ait-Mohand H, Combadiere B et al. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS 2005; 19: 1981-1986. (Pubitemid 41669022)
56. Paiardini M, Cervasi B, Albrecht H, Muthukumar A, Dunham R, Gordon S et al. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol 2005; 174: 2900-2909. (Pubitemid 40279708)
57. MacPherson PA, Fex C, Sanchez-Dardon J, Hawley-Foss N, Angel JB. Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 28: 454-457. (Pubitemid 34033197)
58. Koesters SA, Alimonti JB, Wachihi C, Matu L, Anzala O, Kimani J et al. IL-7Ralpha expression on CD4(+) T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Eur J Immunol 2006; 36: 336-344. (Pubitemid 43257456)
59. Golden-Mason L, Burton JR Jr, Castelblanco N, Klarquist J, Benlloch S, Wang C et al. Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 2006; 44: 1098-1109. (Pubitemid 44748361)
60. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood 2002; 99: 3892-3904. (Pubitemid 35332024)
61. Lang KS, Recher M, Navarini AA, Harris NL, Lohning M, Junt T et al. Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur J Immunol 2005; 35: 738-745. (Pubitemid 40425529)
62. Wherry EJ, Day CL, Draenert R, Miller JD, Kiepiela P, Woodberry T et al. HIV-specific CD8 T cells express low levels of IL-7Ralpha: implications for HIV-specific T cell memory. Virology 2006; 353: 366-373. (Pubitemid 44397137)
63. Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL et al. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 2004; 21: 289-302. (Pubitemid 39094057)
64. Xue HH, Kovanen PE, Pise-Masison CA, Berg M, Radovich MF, Brady JN et al. IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes. Proc Natl Acad Sci U S A 2002; 99: 13759-13764. (Pubitemid 35215454)
65. Young CD, Angel JB. Optimization of culture and storage conditions for an in vitro system to evaluate thymocyte phenotype and function. J Immunol Methods 2006; 312: 157-166. (Pubitemid 43795984)
66. Colle JH, Moreau JL, Fontanet A, Lambotte O, Joussemet M, Delfraissy JF et al. CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients-reversal by highly active anti-retroviral therapy (HAART). Clin Exp Immunol 2006; 143: 398-403.
67. Swainson L, Verhoeyen E, Cosset FL, Taylor N. IL-7R alpha gene expression is inversely correlated with cell cycle progression in IL-7-stimulated T lymphocytes. J Immunol 2006; 176: 6702-6708. (Pubitemid 43787853)
68. Levy Y, Lacabaratz C, Weiss L, Viard JP, Goujard C, Lelievre JD et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest 2009; 119: 997-1007.
69. Sereti I, Dunham RM, Spritzler J, Aga E, Proschan MA, Medvik K et al. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 2009; 113: 6304-6314.
70. Read SW, Higgins J, Metcalf JA, Stevens RA, Rupert A, Nason MC et al. Decreased CD127 expression on T cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy. J Acquir Immune Defic Syndr 2006; 42: 537-544. (Pubitemid 44162421)
71. Beq S, Nugeyre MT, Ho Tsong Fang R, Gautier D, Legrand R, Schmitt N et al. IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. J Immunol 2006; 176: 914-922. (Pubitemid 43099689)
72. Fry TJ, Moniuszko M, Creekmore S, Donohue SJ, Douek DC, Giardina S et al. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 2003; 101: 2294-2299. (Pubitemid 36302072)
73. Rethi B, Fluur C, Atlas A, Krzyzowska M, Mowafi F, Grutzmeier S et al. Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 2005; 19: 2077-2086. (Pubitemid 41668995)
74. Faller E, Kakal J, Kumar R, Macpherson P. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells. Int Immunol 2009; 21: 203-216.
75. Faller EM, Sugden SM, McVey MJ, Kakal JA, MacPherson PA. Soluble HIV Tat protein removes the IL-7 receptor alpha-chain from the surface of resting CD8 T cells and targets it for degradation. J Immunol 2010; 185: 2854-2866.
76. Napolitano LA, Grant RM, Deeks SG, Schmidt D, De Rosa SC, Herzenberg LA et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001; 7: 73-79. (Pubitemid 32095644)
77. Ferrari G, King K, Rathbun K, Place CA, Packard MV, Bartlett JA et al. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp). Clin Exp Immunol 1995; 101: 239-248.
78. Juffroy O, Bugault F, Lambotte O, Landires I, Viard JP, Niel L et al. Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. J Virol 2010; 84: 96-108.
79. Benoit A, Abdkader K, Sirskyj D, Alhetheel A, Sant N, Diaz-Mitoma F et al. Inverse association of repressor growth factor independent-1 with CD8 T cell interleukin (IL)-7 receptor [alpha] expression and limited signal transducers and activators of transcription signaling in response to IL-7 among [gamma]-chain cytokines in HIV patients. AIDS 2009; 23: 1341-1347.
80. Vudattu NK, Magalhaes I, Schmidt M, Seyfert-Margolis V, Maeurer MJ. Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer. Int J Cancer 2007; 121: 1512-1519. (Pubitemid 47328710)
81. Ruiz-Mateos E, de la Rosa R, Franco JM, Martinez-Moya M, Rubio A, Soriano N et al. Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy. AIDS 2003; 17: 947-954. (Pubitemid 36549705)
82. Vranjkovic A, Crawley AM, Angel JB. In vitro HIV type 1 infection indirectly alters CD127 expression on CD8(+) T Cells. AIDS Res Hum Retrov 2011 (in press).
83. Navikas V, Link J, Wahren B, Persson C, Link H. Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol 1994; 96: 59-63. (Pubitemid 24213798)
84. Biglino A, Sinicco A, Forno B, Pollono AM, Sciandra M, Martini C et al. Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. Clin Immunol Immunopathol 1996; 78: 61-69. (Pubitemid 26078312)
85. Douglas SD, Durako S, Sullivan KE, Camarca M, Moscicki AB, Wilson CM. TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths. Clin Diagn Lab Immunol 2003; 10: 399-404. (Pubitemid 36592966)
86. Clerici M, Shearer GM. A TH1->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 107-111. (Pubitemid 23068292)
87. Biasin M, Boasso A, Piacentini L, Trabattoni D, Magri G, Deshmuks R et al. IL-4 and CXCR4 upregulation in HIV-infected and uninfected individuals from Maharashtra-Mumbai. AIDS 2003; 17: 1563-1565. (Pubitemid 36900559)
88. Erard F, Dunbar PR, Le Gros G. The IL4- induced switch of CD8+ T cells to a TH2 phenotype and its possible relationship to the onset of AIDS. Res Immunol 1994; 145: 643-645 discussion 645-646.
89. Crawley AM, Vranjkovic A, Young C, Angel JB. Interleukin-4 downregulates CD127 expression and activity on human thymocytes and mature CD8(+) T cells. Eur J Immunol 2010; 40: 1396-1407.
90. Hoe E, McKay FC, Schibeci SD, Gandhi K, Heard RN, Stewart GJ et al. Functionally significant differences in expression of disease-associated IL-7 receptor {alpha} haplotypes in CD4 T cells and dendritic cells. J Immunol 2010; 184: 2512-2517.
91. Liu X, Leung S, Wang C, Tan Z, Wang J, Guo TB et al. Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat Med 2010; 16: 191-197.
92. Napolitano LA, Schmidt D, Gotway MB, Ameli N, Filbert EL, Ng MM et al. Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest 2008; 118: 1085-1098. (Pubitemid 351364616)
93. Rosenzweig M, Clark DP, Gaulton GN. Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS 1993; 7: 1601-1605. (Pubitemid 24008853)
94. Scinicariello F, Kourtis AP, Nesheim S, Abramowsky C, Lee FK. Limited evolution of human immunodeficiency virus type 1 in the thymus of a perinatally infected child. Clin Infect Dis 2010; 50: 726-732.
95. Ye P, Kirschner DE, Kourtis AP. The thymus during HIV disease: role in pathogenesis and in immune recovery. Curr HIV Res 2004; 2: 177-183. (Pubitemid 38854929)
96. Rose T, Lambotte O, Pallier C, Delfraissy JF, Colle JH. Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients. J Immunol 2009; 182: 7389-7397.
97. Janot-Sardet C, Assouline B, Cheynier R, Morre M, Beq S. A validated assay to measure soluble IL-7 receptor shows minimal impact of IL-7 treatment. J Immunol Methods 2009; 353: 115-123.
98. De Smedt M, Verhasselt B, Kerre T, Vanhecke D, Naessens E, Leclercq G et al. Signals from the IL-9 receptor are critical for the early stages of human intrathymic T cell development. J Immunol 2000; 164: 1761-1767. (Pubitemid 30108727)
99. Perdow-Hickman S, Salgame P. Rescue of human T cells by interleukin-9 (IL-9) from IL-2 deprivation-induced apoptosis: correlation with alpha subunit expression of the IL-9 receptor. J Interferon Cytokine Res 2000; 20: 603-608. (Pubitemid 30429679)
100. Hossain MM, Tsuchie H, Detorio MA, Shirono H, Hara C, Nishimoto A et al. Interleukin-9 receptor alpha chain mRNA formation in CD8+ T cells producing antihuman immunodeficiency virus type 1 substance(s). Acta Virol 1998; 42: 47-53. (Pubitemid 28282653)
101. Sliva D, Zhu YX, Tsai S, Kamine J, Yang YC. Tip60 interacts with human interleukin-9 receptor alpha-chain. Biochem Biophys Res Commun 1999; 263: 149-155. (Pubitemid 29443655)
102. Schluns KS, Williams K, Ma A, Zheng XX, Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 2002; 168: 4827-4831. (Pubitemid 34495942)
103. Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 2002; 17: 537-547. (Pubitemid 35351500)
104. Sandau MM, Schluns KS, Lefrancois L, Jameson SC. Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells. J Immunol 2004; 173: 6537-6541. (Pubitemid 39541036)
105. Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci U S A 2000; 97: 11439-11444.
106. Frohlich A, Kisielow J, Schmitz I, Freigang S, Shamshiev AT, Weber J et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 2009; 324: 1576-1580.
107. Yue FY, Lo C, Sakhdari A, Lee EY, Kovacs CM, Benko E et al. HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. J Immunol 2011; 185: 498-506.
108. Chevalier MF, Julg B, Pyo A, Flanders M, Ranasinghe S, Soghoian DZ et al. HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J Virol 2011; 85: 733-741.
109. Parmigiani A, Pallin MF, Schmidtmayerova H, Lichtenheld MG, Pahwa S. Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells. Hum Immunol 2011; 72: 115-123.
110. Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C et al. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet 2009; 5: e1000322.
111. Do H, Vasilescu A, Diop G, Hirtzig T, Coulonges C, Labib T et al. Associations of the IL2Ralpha, IL4Ralpha, IL10Ralpha, and IFN (gamma) R1 cytokine receptor genes with AIDS progression in a French AIDS cohort. Immunogenetics 2006; 58: 89-98.
112. Soriano A, Lozano F, Oliva H, Garcia F, Nomdedeu M, De Lazzari E et al. Polymorphisms in the interleukin-4 receptor alpha chain gene influence susceptibility to HIV-1 infection and its progression to AIDS. Immunogenetics 2005; 57: 644-654. (Pubitemid 41457486)
113. Chatterjee A, Rathore A, Dhole TN. Association of IL-4 589 C/T promoter and IL-4RalphaI50V receptor polymorphism with susceptibility to HIV-1 infection in North Indians. J Med Virol 2009; 81: 959-965.
114. Romagnani S, Maggi E, Del Prete G. An alternative view of the Th1/Th2 switch hypothesis in HIV infection. AIDS Res Hum Retroviruses 1994; 10: iii-iix.
115. Booth DR, Arthur AT, Teutsch SM, Bye C, Rubio J, Armati PJ et al. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J Mol Med 2005; 83: 822-830. (Pubitemid 41407866)
116. McKay FC, Swain LI, Schibeci SD, Rubio JP, Kilpatrick TJ, Heard RN et al. Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes Immun 2008; 9: 1-6. (Pubitemid 351150028)
117. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, Khademi M et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007; 39: 1108-1113. (Pubitemid 47340654)
118. Limou SCC, Do H, Vasilescu A, Labib T, Gut I, Lelievre JD et al. Identification of an IL-7RA risk allele for rapid progression to AIDS: results of a genomic IL-7/IL-7RA study in the GRIV cohort. 15th Conference on Retroviruses and Opportunistic Infections, February 2008; Boston, MA, USA; poster no. 295 2008.
119. Abrams D, Levy Y, Losso MH, Babiker A, Collins G, Cooper DA et al. Interleukin-2 therapy in patients with HIV infection. N Engl J Med 2009; 361: 1548-1559.
120. Fortis C, Soldini L, Ghezzi S, Colombo S, Tambussi G, Vicenzi E et al. Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2. AIDS Res Hum Retroviruses 2002; 18: 491-499. (Pubitemid 34499725)
121. Leone A, Rohankhedkar M, Okoye A, Legasse A, Axthelm MK, Villinger F et al. Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses. J Immunol 2010; 185: 1650-1659.